Standard
Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. / Kramer, Jocelyn A.; Curran, D.; Piccart, M.; Haes de, J.C.J.M.; Bruning, P.F.; Klijn, J.G.M.; Bontenbal, M.; Pottelsberghe van, C.; Grønvold, Mogens; Paridaens, R.
In:
European Journal of Cancer, No. 36, 2000, p. 1488-1497.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Kramer, JA, Curran, D, Piccart, M, Haes de, JCJM, Bruning, PF, Klijn, JGM, Bontenbal, M, Pottelsberghe van, C, Grønvold, M & Paridaens, R 2000, 'Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist', European Journal of Cancer, no. 36, pp. 1488-1497.
APA
Kramer, J. A., Curran, D., Piccart, M., Haes de, J. C. J. M., Bruning, P. F., Klijn, J. G. M., Bontenbal, M., Pottelsberghe van, C., Grønvold, M., & Paridaens, R. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. European Journal of Cancer, (36), 1488-1497.
Vancouver
Kramer JA, Curran D, Piccart M, Haes de JCJM, Bruning PF, Klijn JGM et al. Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. European Journal of Cancer. 2000;(36):1488-1497.
Author
Kramer, Jocelyn A. ; Curran, D. ; Piccart, M. ; Haes de, J.C.J.M. ; Bruning, P.F. ; Klijn, J.G.M. ; Bontenbal, M. ; Pottelsberghe van, C. ; Grønvold, Mogens ; Paridaens, R. / Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. In: European Journal of Cancer. 2000 ; No. 36. pp. 1488-1497.
Bibtex
@article{346cfa4074c811dbbee902004c4f4f50,
title = "Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist",
abstract = "Cancer, Health-related quality of life",
author = "Kramer, {Jocelyn A.} and D. Curran and M. Piccart and {Haes de}, J.C.J.M. and P.F. Bruning and J.G.M. Klijn and M. Bontenbal and {Pottelsberghe van}, C. and Mogens Gr{\o}nvold and R. Paridaens",
year = "2000",
language = "English",
pages = "1488--1497",
journal = "European Journal of Cancer, Supplement",
issn = "0959-8049",
publisher = "Pergamon",
number = "36",
}
RIS
TY - JOUR
T1 - Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
AU - Kramer, Jocelyn A.
AU - Curran, D.
AU - Piccart, M.
AU - Haes de, J.C.J.M.
AU - Bruning, P.F.
AU - Klijn, J.G.M.
AU - Bontenbal, M.
AU - Pottelsberghe van, C.
AU - Grønvold, Mogens
AU - Paridaens, R.
PY - 2000
Y1 - 2000
N2 - Cancer, Health-related quality of life
AB - Cancer, Health-related quality of life
M3 - Journal article
SP - 1488
EP - 1497
JO - European Journal of Cancer, Supplement
JF - European Journal of Cancer, Supplement
SN - 0959-8049
IS - 36
ER -
